News Cigna

Equities

CI

US1255231003

Market Closed - Nyse Other stock markets 04:00:02 2024-04-25 pm EDT			Pre-market 07:00:13 am
354.5 ^USD	+0.63%		352	-0.71%

Apr. 25	Cigna's Evernorth to Offer Humira Biosimilar Without Out-of-Pocket Fee	DJ
Apr. 25	Cigna to offer Humira rivals with $0 copay at specialty pharmacy	RE

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Cigna's Evernorth to Offer Humira Biosimilar Without Out-of-Pocket Fee	Apr. 25	DJ
Cigna to offer Humira rivals with $0 copay at specialty pharmacy	Apr. 25	RE
AM Best Affirms Credit Ratings of The Cigna Group and Its Subsidiaries	Apr. 25	BU
Cigna Group Keeps Quarterly Cash Dividend at $1.40 a Share, Payable June 20 to Holders of Record June 4	Apr. 24	MT
The Cigna Group Declares Quarterly Dividend	Apr. 24	PR
The Cigna Group Declares Quarterly Dividend, Payable on June 20, 2024	Apr. 24	CI
The Cigna Group Announces Appearance at the BofA Securities 2024 Health Care Conference	Apr. 23	PR
Lost In Interpretation: How Claim Construction Doomed AlexSam's Case Against Cigna	Apr. 23	AQ
Cigna, Humana Merger Now Seems Plausible, Jefferies Says	Apr. 22	MT
The Cigna Group Foundation Announces New Grant Program To Address Youth Mental Health Crisis	Apr. 18	PR
CVS, Cigna, Humana, UnitedHealth - Congress wants to clean up PBMs	Apr. 17
Explainer-Why are US pharmacy benefit managers under fire?	Apr. 16	RE
Truist Securities Raises Price Target on Cigna to $420 From $400	Apr. 15	MT
National Center for Public Files an Exempt Solicitation Statement and Request Vote for the Proposal	Apr. 11	CI
The Cigna Group's First Quarter 2024 Earnings Release Details	Apr. 11	PR
The Cigna Group Named Among Best Employers for Health and Well-Being	Apr. 09	PR
Boehringer to lay off salespeople as Humira biosimilar sales lag	Apr. 05	RE
Boehringer to lay off salespeople as Humira biosimilar sales lag	Apr. 04	RE
US health insurers slide as final Medicare payment rates fall short of expectations	Apr. 02	RE
US health insurers slide as final Medicare Advantage rate sparks margin hit fears	Apr. 02	RE

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

+39.41% on our US portfolio vs. 25.67% on the S&P 500 net Total Return

Replicate our performance

fermer